PRIME: Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational Study

Sponsor
Rovere Querini Patrizia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05723185
Collaborator
ASST Fatebenefratelli Sacco (Other), ASST Grande Ospedale Metropolitano Niguarda (Other)
246
1
11.8
20.9

Study Details

Study Description

Brief Summary

This is a multicentric, prospective, observational study with two cohorts and adjunctive procedure. It aims at collecting and analyzing data about the function of an innovative hospital-territory integration health service for the management of patients with intermediate urgency, or emergency department "white codes." This service, activated in the participating centers, will be provided in two alternative modalities, one so-called "dual specialty" (cardiology and diabetes specialist outpatient clinic) and a second one more focused on the figure of the specialist in Internal Medicine.

We will monitor the population treated in these centers (presenting complaint, medical history, clinical-radiological data, performed therapies and overall health path) and the degree of satisfaction of the GPs who sent their patients there and the degree of satisfaction of the patients themselves. The data collected will also be used to evaluate the effectiveness of the outpatient clinics in terms of reducing improper admissions to the PS and hospitalizations. The two modes of service delivery will be compared.

This is an 18-month study, sponsored by our Scientific Directorate and carried out on a nonprofit basis. The study will enroll 246 patients and 30 healthy volunteer General Practitioners. The clinical trial will be conducted in accordance with Good Clinical Practice standards.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
246 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational Study
Anticipated Study Start Date :
Feb 6, 2023
Anticipated Primary Completion Date :
Jan 31, 2024
Anticipated Study Completion Date :
Jan 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Internal medicine model

This group of patients will be treated at the outpatient clinic which is run by internal medicine specialists

Other: Outpatient visit
Patients will be seen and treated at the outpatient clinic like in the usual care

Specialist model

This group of patients will be treated at the outpatient clinic which is run by cardiologists and/or diabetologists

Other: Outpatient visit
Patients will be seen and treated at the outpatient clinic like in the usual care

Outcome Measures

Primary Outcome Measures

  1. Analyse and compare the function of the two outpatient clinic models [6 months for each subject]

    We will gather data describing the different patients treated at the two outpatient clinics; moreover, we will describe the timing, efficiency and effectiveness of the interventions and compare the two models; lastly, feedback from patients and general practitioners will be gathered through questionnaires

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients sent by General Practitioners for outpatient evaluation in the two models

  • Patients able to read and sign the informed consent

  • Patients able to read and fill the questionnaire

Exclusion Criteria:
  • Pregnant women

Contacts and Locations

Locations

Site City State Country Postal Code
1 San Raffaele Hospital Milan Italy

Sponsors and Collaborators

  • Rovere Querini Patrizia
  • ASST Fatebenefratelli Sacco
  • ASST Grande Ospedale Metropolitano Niguarda

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Rovere Querini Patrizia, MD, PhD, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT05723185
Other Study ID Numbers:
  • PRIME
First Posted:
Feb 10, 2023
Last Update Posted:
Feb 10, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2023